HR 6216 United States House · 117th Congress

Sickle Cell Disease Comprehensive Care Act

Summary
Sickle Cell Disease Comprehensive Care Act This bill establishes and provides funds for a demonstration project for state Medicaid programs to improve outpatient care for individuals with sickle cell disease, with a focus on young adults and pregnant women. The Centers for Medicare & Medicaid Services must award planning grants to at least 10 states and must select between 5 and 10 states to participate in the project. Participating states must provide specified services and support for individuals with sickle cell disease, including multidisciplinary care teams, appropriate treatments, mental health services, and specialist services. The bill provides a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for services provided through the project.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2021
Committee Review
Floor Vote
President
Introduced Dec 9, 2021 Last action Dec 10, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Dec 10, 2021
Committee
Referred to the Subcommittee on Health.
lower
Dec 9, 2021
Committee
Referred to the House Committee on Energy and Commerce.
lower
Dec 9, 2021
Introduced
Introduced in House
lower
1 primary · 17 co-sponsors

Sponsors